Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Retinoblastoma × Topotecan × Clear all

Phase

Phase 3 2 Phase 2 2 Phase 1 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neuroectodermal Tumors, Primitive, Peripheral 2 Retinoblastoma 1 Ovarian Neoplasms 1 Neuroblastoma 1 Lymphoma 1 Central Nervous System Neoplasms 1

Interventions

Carboplatin 4 Melphalan 3 Vincristine 2 Etoposide 2 etoposide phosphate 1 Watchful Waiting 1 Ursodeoxycholic Acid 1 Topotecan 1 Thiotepa 1 Saline Solution 1 Radiotherapy 1 Radiation 1 Photochemotherapy 1 Paclitaxel 1 Nitroglycerin 1 Neoadjuvant Therapy 1 Mesna 1 Leukapheresis 1 Ifosfamide 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Dexmedetomidine 1 Cytarabine 1 Cryotherapy 1 Chemotherapy, Adjuvant 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00980551 2017-03-03

RELRB1

Children's Hospital Medical Center, Cincinnati

Phase NA Withdrawn

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡